Why is Medical Net, Inc. ?
1
High Management Efficiency with a high ROE of 11.74%
2
Company has very low debt and has enough cash to service the debt requirements
- PRE-TAX PROFIT(Q) At JPY 60.95 MM has Fallen at -58.01%
- NET PROFIT(Q) At JPY 34.63 MM has Fallen at -71.77%
- RAW MATERIAL COST(Y) Grown by 6.34% (YoY)
3
With ROE of 26.79%, it has a expensive valuation with a 1.65 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -23.51%, its profits have risen by 568.3% ; the PEG ratio of the company is 0
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -23.51% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Medical Net, Inc. should be less than 10%
- Overall Portfolio exposure to Media & Entertainment should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Media & Entertainment)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Medical Net, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Medical Net, Inc.
-23.51%
-1.76
21.01%
Japan Nikkei 225
88.41%
3.12
27.27%
Quality key factors
Factor
Value
Sales Growth (5y)
16.18%
EBIT Growth (5y)
-8.01%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
1.92
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.00%
ROE (avg)
11.74%
Valuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
1.65
EV to EBIT
17.88
EV to EBITDA
11.61
EV to Capital Employed
1.96
EV to Sales
0.40
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
10.96%
ROE (Latest)
26.79%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
12What is working for the Company
NET PROFIT(HY)
At JPY 103.86 MM has Grown at 336.7%
ROCE(HY)
Highest at 11.11%
CASH AND EQV(HY)
Highest at JPY 3,920.89 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -33.87 %
-19What is not working for the Company
PRE-TAX PROFIT(Q)
At JPY 60.95 MM has Fallen at -58.01%
NET PROFIT(Q)
At JPY 34.63 MM has Fallen at -71.77%
RAW MATERIAL COST(Y)
Grown by 6.34% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.71 times
INTEREST(Q)
Highest at JPY 4.11 MM
Here's what is working for Medical Net, Inc.
Cash and Eqv
Highest at JPY 3,920.89 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -33.87 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Medical Net, Inc.
Pre-Tax Profit
At JPY 60.95 MM has Fallen at -58.01%
over average net sales of the previous four periods of JPY 145.13 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 34.63 MM has Fallen at -71.77%
over average net sales of the previous four periods of JPY 122.67 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Interest
At JPY 4.11 MM has Grown at 13.96%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Interest
Highest at JPY 4.11 MM
in the last five periods and Increased by 13.96% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Debtors Turnover Ratio
Lowest at 6.71 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 6.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






